SRF is expanding its fluorochemicals business across India, Bangladesh, Argentina, Thailand, Greece and Taiwan. Its strong FCF, robust balance sheet, premium valuation are the other factors that have made the company a favourite of analysts.
Helped by lower tax rate and strong performance of the chemicals and packaging segment, SRF reported a robust set of numbers for the fourth quarter of 2021-22. The reported net profit of `606 crore was 5.6% higher than the consensus estimate of analysts compiled by Bloomberg. Its operating profit and net profit grew 47% and 59% y-o-y respectively. The company’s EBIT margins also improved in the fourth quarter as it was able to partially pass
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Comment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise